Increased glycan chain length distribution and decreased susceptibility to moenomycin in a vancomycin-resistant Staphylococcus aureus mutant

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 1, 2002, Pages 75-81

  Komatsuzawa, H ^a   Ohta, K ^a   Yamada, S ^a   Ehlert, K ^a   Labischinski, H ^a   Kajimura, J ^a   Fujiwara, T ^a   Sugai, M ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN; BACTERIAL PROTEIN; BAMBERMYCIN; FOSFOMYCIN; GLYCAN; GLYCOSYLTRANSFERASE; HYDROLASE; MACARBOMYCIN; METICILLIN; MUROPEPTIDE; OXACILLIN; PENICILLIN BINDING PROTEIN; PENICILLIN BINDING PROTEIN 1; PENICILLIN BINDING PROTEIN 2; PENICILLIN BINDING PROTEIN 3; PENICILLIN BINDING PROTEIN 4; PENICILLIN BINDING PROTEIN 5; PENICILLIN G; PEPTIDOGLYCAN; TEICOPLANIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CELL WALL; BACTERIOLYSIS; BACTERIUM ISOLATE; BACTERIUM MUTANT; CONTROLLED STUDY; CROSS LINKING; DRUG MECHANISM; ENZYME INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STAPHYLOCOCCUS AUREUS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; MUTATION; OLIGOSACCHARIDES; PEPTIDOGLYCAN; POLYSACCHARIDES; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 0036136114     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.1.75-81.2002     Document Type: Article

References (35)

1. The structure and mode of action of glycopeptide antibiotics of the vancomycin group
2. Involvement of multiple genetic loci in Staphylococcus aureus teicoplanin resistance
3. Clinical isolate of vancomycin-heteroint-ermediate Staphylococcus aureus susceptible to methicillin and in vitro selection of a vancomycin-resistant derivative
4. Characterization of Staphylococcus aureus cell wall glycan strands, evidence for a new endo-β-N-acetylglucosaminidase activity
5. +-dependent D-lactate dehydrogenase and insertional inactivation in a glycopeptide-resistant isolate
6. A spectrum of changes occurs in peptidoglycan composition of glycopeptide-intermediate clinical Staphylococcus aureus isolates
7. Inactivation of a novel three-cistronic operon tcaR-tcaA-tcaB increases teicoplanin resistance in Staphylococcus aureus
8. Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50
9. Multimodular penicillin-binding proteins: An enigmatic family of orthologs and paralogs
10. Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu 50
11. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin
12. Moenomycin, an inhibitor of cell wall synthesis
13. Cloning and characterization of a gene, pbpF, encoding a new penicillin-binding protein, PBP 2B, in Staphylococcus aureus
14. Triton X-100 alters the resistance level of methicillin-resisrant Staphylococcus aureus to oxacillin
15. The effect of Triton X-100 on the in-vitro susceptibility of methicillin-resistant Staphylococcus aureus to oxacillin
16. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital
17. Staphylococcus aureus and Micrococcus luteus peptidoglycan transglycosylases that are not penicillin-binding proteins
18. +-linked D-lactate dehydrogenase associated with vancomycin resistance in Staphylococcus aureus
19. Increased production of penicillin-binding protein 2, increased detection of other penicillin-binding proteins, and decreased coagulase activity associated with glycopeptide resistance in Staphylococcus aureus
20. Nucleotide sequence of the structural gene for the penicillin-binding protein 2 of Staphylococcus aureus and the presence of a homologous gene in other staphylococci
21. Zymographic characterization of Staphylococcus aureus cell wall
22. A Staphylococcus aureus autolysin that has an N-acetylmuramoylL-alanine amidase domain and an endo-β-N-acetylglucosaminidase domain: Cloning, sequence analysis, and characterization
23. Cloning, characterization, and inactivation of the gene pbpC, encoding penicillin-binding protein 3 of Staphylococcus aureus
24. Improved high-performance liquid chromatographic separation of peptidoglycan isolated from various Staphylococcus aureus strains for mass spectrometric characterization
25. Teicoplanin-resistant Staphylococcus aureus expresses a novel membrane protein and increases expression of penicillin-binding protein 2 complex
26. Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus
27. The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection
28. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus
29. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus
30. Emergence of vancomycin resistance in Staphylococcus aureus
31. Cell wall monoglycine cross-bridges and methicillin hypersusceptibility in a femAB null mutant of methicillin-resistant Staphylococcus aureus
32. Characterization of sodium dodecyl sulfate-stable Staphylococcus aureus bacteriolytic enzymes by polyacrylamide gel electrophoresis
33. Macarbomycin, an inhibitor of peptidoglycan synthesis
34. Polymerization by transglycosylation in the biosynthesis of the peptidoglycan of Escherichia coli K12 and its inhibition by antibiotics
35. Distribution of WGA-binding sites on the surface of clinical isolates of Staphylococcus aureus